ClinicalTrials.gg
CompletedNCT05785572Updated Nov 16, 2026

Effect of Radiofrequency of Suprascapular Nerve in Shoulder Reverse Arthroplasty

An interventional study of supraescapular nerve radiofrequency and interescalenic braquial plexus in Rotator Cuff Tear Arthropathy and Post Operative Pain, sponsored by Hospital Universitario Virgen Macarena. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Hospital Universitario Virgen Macarena · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jul 2021, registered Mar 2023).
Updated Nov 16, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpuse of this study is to asses if the pulsed radiofrecuency of the supraescapular nerve and accesory nerve have the same or superior efectivity controlling the acute postoperative pain than interscalenic braquial plexus block

Read the detailed description

This is a randomized, double-blind trial that compares the effect in postoperative pain of pulsed radiofrecuency of the supraescapular nerve carried out at least two to four weeks before reverse total shoulder arthroplasty surgery with interscalenic braquial plexus block done at the moment of the surgery. All the patients received conventional general anaesthesia and multimodal postoperative analgesia with additional patient-controlled rescue analgesics were prescribed

02

Conditions studied

  • Rotator Cuff Tear Arthropathy
  • Post Operative Pain

Keywords

  • rotator cuff arthropathy
  • reverse shoulder arthroplasty
  • supraescapular nerve radiofrecuency
  • post operative pain
03

In context

Rotator Cuff Tear Arthropathy

57 studies on the registry are indexed under Rotator Cuff Tear Arthropathy; 14 are open to participants now.

This study's enrollment of 62 is below the median of 90 across 33 interventional studies indexed under Rotator Cuff Tear Arthropathy.

Browse Rotator Cuff Tear Arthropathy studies →

Lead sponsor

Hospital Universitario Virgen Macarena is the lead sponsor of 18 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Over 18 y.o.
  • Cronic pain (more than 3 months) due to rotator cuff arthropathy
  • VAS higher than 4
  • Decrease Constant score
  • Conservative treatment (physiotherapy and NSAIs) unsuccessful

Exclusion criteria

Exclusion criteria:

  • psychiatric illness
  • drug abuse.
  • previous surgeries.
  • acute traumatic pathology or ethiology different from rotator cuff arthropathy
  • pacemaker
  • infectious process
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Radiofrequency group

    Patient group that undergoes Radiofrequency of supraescapular nerve before shoulder arthroplasty surgery

    Procedure: supraescapular nerve radiofrequency

  • Active comparator
    Interscalenic braquial plexus block group

    Interscalenic braquial plexus block done at the moment of the surgery.

    Procedure: interescalenic braquial plexus

Interventions

  • Proceduresupraescapular nerve radiofrequency

    supraescapular nerve radiofrequency or interescalenic braquial plexus for pain control in shoulder arthroplasty surgery

  • Procedureinterescalenic braquial plexus

    supraescapular nerve radiofrequency or interescalenic braquial plexus for pain control in shoulder arthroplasty surgery

06

What researchers measure

Primary outcomes

  1. Visual analogical scale

    Postoperative acute pain measurement. From 0 to 10, Zero means no pain and ten would be the worse pain that the paitient could feel.

    Time frame: periodical measurements of pain, inmediate preoperative pain up to three months postoperative

Secondary outcomes

  1. Visual analogical scale

    chronic pain after surgery. From 0 to 10, Zero means no pain and ten would be the worse pain that the paitient could feel.

    Time frame: 3 months postop. until 1 year postop

07

Study locations

1 site
  • Hospital Universitario Virgen Macarena
    Seville, Sevilla 41009, Spain
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2021 to primary completion in Oct 2025, 51 months.

Of 20 interventional studies with no phase under Rotator Cuff Tear Arthropathy, half reached primary completion within 69 months of starting (the median), counting those still running; a quarter within 45 and three quarters within 72. This study's 51 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jul 2023 → Oct 2025 and completion Jul 2024 → Dec 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 15, 2023
First posted
Mar 27, 2023
StartActual
Jul 1, 2021
Primary completionActual
Oct 1, 2025was Jul 2023
CompletionActual
Dec 1, 2025was Jul 2024
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 16, 2026
Sites
1 site added, 1 site removed
Show site
  • Hospital Universitario Virgen Macarena · Seville, Spain
Show 1 removed
  • Hospital Universitario Virgen Macarena · Sevilla, Spain
Nov 16, 2026
Primary completion
Jul 1, 2023→Oct 1, 2025 (actual)
Nov 16, 2026
Study completion
Jul 1, 2024→Dec 1, 2025 (actual)
Nov 16, 2026
Enrollment
54 (estimated)→62 (actual)
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Status unknown→Completed
    1 site added, 1 site removed
    Show site
    • Hospital Universitario Virgen Macarena · Seville, Spain
    Show 1 removed
    • Hospital Universitario Virgen Macarena · Sevilla, Spain
    Primary completion Jul 1, 2023→Oct 1, 2025 (now actual)
    Study completion Jul 1, 2024→Dec 1, 2025 (now actual)
    Enrollment 54 (estimated)→62 (actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05785572
Lead sponsor
Hospital Universitario Virgen Macarena
Responsible party
Sponsor
First posted
Mar 27, 2023
Start date
Jul 1, 2021
Primary completion
Oct 1, 2025
Completion
Dec 1, 2025
Last update
Nov 16, 2026

Study contacts

Jose Manuel Lopez Millan
principal investigator · Hospital Universitario Virgen Macarena

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion